Seguir
KUMIKO A. IWABUCHI
KUMIKO A. IWABUCHI
Shinobi Therapeutics, Jichi Medical University
Dirección de correo verificada de kyoto-u.jp
Título
Citado por
Citado por
Año
Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation
S Matoba, Y Liu, F Lu, KA Iwabuchi, L Shen, A Inoue, Y Zhang
Cell 159 (4), 884-895, 2014
5052014
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping
P Gee, MSY Lung, Y Okuzaki, N Sasakawa, T Iguchi, Y Makita, H Hozumi, ...
Nature communications 11 (1), 1334, 2020
2912020
High-resolution analysis with novel cell-surface markers identifies routes to iPS cells
J O’Malley, S Skylaki, KA Iwabuchi, E Chantzoura, T Ruetz, A Johnsson, ...
Nature 499 (7456), 88-91, 2013
1922013
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
E Kenjo, H Hozumi, Y Makita, KA Iwabuchi, N Fujimoto, S Matsumoto, ...
Nature communications 12 (1), 7101, 2021
1632021
Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells
M Imamura, K Miura, K Iwabuchi, T Ichisaka, M Nakagawa, J Lee, ...
BMC developmental biology 6, 1-16, 2006
1472006
Loss of H3K27me3 imprinting in somatic cell nuclear transfer embryos disrupts post-implantation development
S Matoba, H Wang, L Jiang, F Lu, KA Iwabuchi, X Wu, K Inoue, L Yang, ...
Cell stem cell 23 (3), 343-354. e5, 2018
1402018
Restoration of dystrophin protein expression by exon skipping utilizing CRISPR-Cas9 in myoblasts derived from DMD patient iPS cells
M Ifuku, KA Iwabuchi, M Tanaka, MSY Lung, A Hotta
Exon Skipping and Inclusion Therapies: Methods and Protocols, 191-217, 2018
252018
ECAT11/L1td1 is enriched in ESCs and rapidly activated during iPSCGeneration, but it is dispensable for the maintenance and induction of pluripotency
KA Iwabuchi, T Yamakawa, Y Sato, T Ichisaka, K Takahashi, K Okita, ...
PLoS One 6 (5), e20461, 2011
232011
Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity
A Gravina, G Tediashvili, Y Zheng, KA Iwabuchi, SM Peyrot, SZ Roodsari, ...
Cell Stem Cell 30 (11), 1538-1548. e4, 2023
82023
Generation of induced pluripotent stem cells from human melanoma tumor-infiltrating lymphocytes
H Saito, K Iwabuchi, N Fusaki, F Ito
Journal of visualized experiments: JoVE, 2016
72016
Embryonic Stem Cell Proliferation Stimulated By Altered Anabolic Metabolism From Glucose Transporter 2-Transported Glucosamine.
MRL Jin Hyuk Jung, Kumiko Iwabuchi, Zhihong Yang
Scientific Reports 6 (28452), 2016
62016
Composition for modifying target gene
A Hotta, M Ifuku, N Fujimoto, K Iwabuchi, E Kenjo, Y Makita, R Ochiai
US Patent 12,031,130, 2024
12024
New marker for detection of induced pluripotent stem cell
S Yamanaka, K Iwabuchi
WO2010137744, 2010
12010
Hormone and nuclear receptor activations are required for cardiomyocyte maturation
N Chanthra, RE Ahmed, T Anzai, T Tokuyama, KA Iwabuchi, Y Hanazono, ...
Journal of Molecular and Cellular Cardiology 173, S182, 2022
2022
COMPOSITION FOR MODIFYING A GOAL GENE
A Hotta, M Ifuku, N Fujimoto, K Iwabuchi, E KENJO, Y MAKITA, R Ochiai
2021
Comprehensive profiling of TCR and BCR repertoire of infiltrated lymphocytes in the mouse injured skeletal muscle
KA Iwabuchi, N Sasakawa, A Hotta
The Journal of Immunology 204 (1_Supplement), 86.6-86.6, 2020
2020
Nanomembrane-Derived Extracellular Vesicles for the Delivery of Crispr-Cas9/Grna for Therapeutic Exon Skipping in Duchenne Muscular Dystrophy
A Hotta, P Gee, MSY Lung, Y Okuzaki, N Sasakawa, T Iguchi, Y Makita, ...
MOLECULAR THERAPY 28 (4), 565-565, 2020
2020
ゲノム編集技術とその応用の現状
岩渕久美子, 堀田秋津
血液フロンティア= Hematology frontier 28 (3), 343-352, 2018
2018
Identifying and Overcoming an Epigenetic Barrier for SCNT Reprogramming
Y Zhang, S Matoba, Y Liu, F Lu, K Iwabuchi, L Shen, A Inoue
International Journal of Fertility & Sterility 9, 15, 2015
2015
ECAT11/L1td1 is enriched in ESCs and rapidly activated during iPSC generation, but it is dispensable for the pluripotency
K Iwabuchi
Kyoto University, 2011
2011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20